175 related articles for article (PubMed ID: 17448572)
1. Enhanced proteasome-dependent degradation of the CDK inhibitor p27(kip1) in immortalized lymphocytes from Alzheimer's dementia patients.
Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
Neurobiol Aging; 2008 Oct; 29(10):1474-84. PubMed ID: 17448572
[TBL] [Abstract][Full Text] [Related]
2. Cellular mechanism through which parathyroid hormone-related protein induces proliferation in arterial smooth muscle cells: definition of an arterial smooth muscle PTHrP/p27kip1 pathway.
Fiaschi-Taesch N; Sicari BM; Ubriani K; Bigatel T; Takane KK; Cozar-Castellano I; Bisello A; Law B; Stewart AF
Circ Res; 2006 Oct; 99(9):933-42. PubMed ID: 17023675
[TBL] [Abstract][Full Text] [Related]
3. HMG-CoA reductase inhibitor simvastatin inhibits cell cycle progression at the G1/S checkpoint in immortalized lymphocytes from Alzheimer's disease patients independently of cholesterol-lowering effects.
Sala SG; Muñoz U; Bartolomé F; Bermejo F; Martín-Requero A
J Pharmacol Exp Ther; 2008 Jan; 324(1):352-9. PubMed ID: 17928568
[TBL] [Abstract][Full Text] [Related]
4. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
5. Enhanced proliferation of lymphoblasts from patients with Alzheimer dementia associated with calmodulin-dependent activation of the na+/H+ exchanger.
Urcelay E; Ibarreta D; Parrilla R; Ayuso MS; Martín-Requero A
Neurobiol Dis; 2001 Apr; 8(2):289-98. PubMed ID: 11300724
[TBL] [Abstract][Full Text] [Related]
6. The hedgehog pathway inhibitor cyclopamine increases levels of p27, and decreases both expression of IGF-II and activation of Akt in PC-3 prostate cancer cells.
Levitt RJ; Zhao Y; Blouin MJ; Pollak M
Cancer Lett; 2007 Oct; 255(2):300-6. PubMed ID: 17602833
[TBL] [Abstract][Full Text] [Related]
7. Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts.
Cavazzin C; Bonvicini C; Nocera A; Racchi M; Kasahara J; Tardito D; Gennarelli M; Govoni S; Racagni G; Popoli M
Neurobiol Aging; 2004 Oct; 25(9):1187-96. PubMed ID: 15312964
[TBL] [Abstract][Full Text] [Related]
8. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
[TBL] [Abstract][Full Text] [Related]
9. Ca2+/calmodulin-dependent modulation of cell cycle elements pRb and p27kip1 involved in the enhanced proliferation of lymphoblasts from patients with Alzheimer dementia.
de las Cuevas N; Urcelay E; Hermida OG; Saíz-Diaz RA; Bermejo F; Ayuso MS; Martín-Requero A
Neurobiol Dis; 2003 Aug; 13(3):254-63. PubMed ID: 12901840
[TBL] [Abstract][Full Text] [Related]
10. Evidence for cytosolic p27(Kip1) ubiquitylation and degradation during adipocyte hyperplasia.
Auld CA; Morrison RF
Obesity (Silver Spring); 2006 Dec; 14(12):2136-44. PubMed ID: 17189539
[TBL] [Abstract][Full Text] [Related]
11. Retinoic acid stabilizes p27Kip1 in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45Skp2 and Cks1 proteins.
Zancai P; Dal Col J; Piccinin S; Guidoboni M; Cariati R; Rizzo S; Boiocchi M; Maestro R; Dolcetti R
Oncogene; 2005 Apr; 24(15):2483-94. PubMed ID: 15735731
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma.
Kudo Y; Kitajima S; Ogawa I; Miyauchi M; Takata T
Oral Oncol; 2005 Feb; 41(2):105-16. PubMed ID: 15695111
[TBL] [Abstract][Full Text] [Related]
13. On the mechanism of inhibition of p27 degradation by 15-deoxy-Delta12,14-prostaglandin J2 in lymphoblasts of Alzheimer's disease patients.
Muñoz U; Bartolomé F; Esteras N; Bermejo-Pareja F; Martín-Requero A
Cell Mol Life Sci; 2008 Nov; 65(21):3507-19. PubMed ID: 18818877
[TBL] [Abstract][Full Text] [Related]
14. The unfolded protein response affects neuronal cell cycle protein expression: implications for Alzheimer's disease pathogenesis.
Hoozemans JJ; Stieler J; van Haastert ES; Veerhuis R; Rozemuller AJ; Baas F; Eikelenboom P; Arendt T; Scheper W
Exp Gerontol; 2006 Apr; 41(4):380-6. PubMed ID: 16564150
[TBL] [Abstract][Full Text] [Related]
15. Calpain activation is required for glutamate-induced p27 down-regulation in cultured cortical neurons.
Akashiba H; Matsuki N; Nishiyama N
J Neurochem; 2006 Nov; 99(3):733-44. PubMed ID: 16824045
[TBL] [Abstract][Full Text] [Related]
16. Modified p27 Kip1 is efficient in suppressing HER2-mediated tumorigenicity.
Yang HY; Yang H; Zhao R; Lee MH
J Cell Biochem; 2006 May; 98(1):128-38. PubMed ID: 16365885
[TBL] [Abstract][Full Text] [Related]
17. Regulation of nuclear Prointerleukin-16 and p27(Kip1) in primary human T lymphocytes.
Wilson KC; Cattel DJ; Wan Z; Rahangdale S; Ren F; Kornfeld H; Sullivan BA; Cruikshank WW; Center DM
Cell Immunol; 2005 Sep; 237(1):17-27. PubMed ID: 16289056
[TBL] [Abstract][Full Text] [Related]
18. Akt regulates vitamin D3-induced leukemia cell functional differentiation via Raf/MEK/ERK MAPK signaling.
Wang J; Zhao Y; Kauss MA; Spindel S; Lian H
Eur J Cell Biol; 2009 Feb; 88(2):103-15. PubMed ID: 19058874
[TBL] [Abstract][Full Text] [Related]
19. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance.
Li L; Iwamoto Y; Berezovskaya A; Boussiotis VA
Nat Immunol; 2006 Nov; 7(11):1157-65. PubMed ID: 17013388
[TBL] [Abstract][Full Text] [Related]
20. Partial inhibition of the proteasome enhances the activity of the myelin basic protein promoter.
Calatayud CA; García CI; Paez PM; Pasquini JM; Soto EF; Pasquini LA
Dev Neurosci; 2009; 31(3):169-80. PubMed ID: 19145069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]